Molecular modeling aided design of nicotinic acid receptor GPR109A agonists

Bioorganic & Medicinal Chemistry Letters
2008.0

Abstract

A homology model of the nicotinic acid receptor GPR109A was constructed based on the X-ray crystal structure of bovine rhodopsin. An HTS hit was docked into the homology model. Characterization of the binding pocket by a grid-based surface calculation of the docking model suggested that a larger hydrophobic body plus a polar tail would improve interaction between the ligand and the receptor. The designed compounds were synthesized, and showed significantly improved binding affinity and activation of GPR109A.

Knowledge Graph

Similar Paper

Molecular modeling aided design of nicotinic acid receptor GPR109A agonists
Bioorganic & Medicinal Chemistry Letters 2008.0
Evaluation of Molecular Modeling of Agonist Binding in Light of the Crystallographic Structure of an Agonist-Bound A<sub>2A</sub>Adenosine Receptor
Journal of Medicinal Chemistry 2012.0
Discovery of pyrazolopyrimidines as the first class of allosteric agonists for the high affinity nicotinic acid receptor GPR109A
Bioorganic &amp; Medicinal Chemistry Letters 2008.0
Structure–activity relationships of trans-substituted-propenoic acid derivatives on the nicotinic acid receptor HCA2 (GPR109A)
Bioorganic &amp; Medicinal Chemistry Letters 2011.0
Insights into the Structural Determinants Required for High-Affinity Binding of Chiral Cyclopropane-Containing Ligands to α4β2-Nicotinic Acetylcholine Receptors: An Integrated Approach to Behaviorally Active Nicotinic Ligands
Journal of Medicinal Chemistry 2012.0
Affinity of aporphines for the human 5-HT2A receptor: Insights from homology modeling and molecular docking studies
Bioorganic &amp; Medicinal Chemistry 2010.0
Nicotinic Acid Receptor Agonists
Journal of Medicinal Chemistry 2008.0
Agonist lead identification for the high affinity niacin receptor GPR109a
Bioorganic &amp; Medicinal Chemistry Letters 2007.0
Molecular modeling of the human P2Y14 receptor: A template for structure-based design of selective agonist ligands
Bioorganic &amp; Medicinal Chemistry 2015.0
Discovery of coumarin-dihydroquinazolinone analogs as niacin receptor 1 agonist with in-vivo anti-obesity efficacy
European Journal of Medicinal Chemistry 2018.0